芳基环己胺

芳基环己胺衍生物（英語：、arylcyclohexamines或arylcyclohexanamines）是一类含氮有机化合物，常用作药品和狡詐家藥物和试验药物，其特点是环己烷的一个碳原子上连接了氨基的N原子和芳香基，常见的有乙环利定、苯环己哌啶等[1]。

芳基环己胺的各个取代基
从左至右依次是4-甲基-PCP、4'-甲基-PCP、4''-甲基-PCP
苯环己哌啶，最常见的芳基环己胺衍生物

化合物
结构 化合物 分子式 芳香基团 含N取代基 环己烷侧取代基 CAS编号
PCA[2]C12H17N苯基NH2-1934-71-0
PCM[2]C13H19N苯基甲氨基-2201-16-3
乙环利定（PCE）C14H21N苯基乙氨基-2201-15-2
PCPr[3]C15H23N苯基正丙氨基-18949-81-0
PCiPC15H23N苯基异丙氨基-1195-42-2
PCAL [4]C15H21N苯基烯丙氨基-2185-95-7
PCBuC16H25N苯基正丁氨基-73166-29-7
PCEOHC14H21NO苯基羟乙氨基-2201-22-1
PCMEA[5]C15H23NO苯基甲氧乙氨基-2201-57-2
PCEEAC16H25NO苯基乙氧乙氨基-1072895-05-6
PCMPAC16H25NO苯基甲氧丙氨基-2201-58-3
PCDM[2]C14H21N苯基二甲氨基-2201-17-4
二乙环利定（PCDE）C16H25N苯基二乙氨基-2201-19-6
2-HO-PCP[6]C17H25NO苯基哌啶基2-羟基94852-58-1
2-Me-PCP[7]C18H27N苯基哌啶基2-甲基59397-29-4
2-MeO-PCP[8]C18H27NO苯基哌啶基2-甲氧基78636-34-7
2-Keto-PCPC17H23NO苯基哌啶基2-酮101688-16-8
2-氧代-PCE（"O-PCE"）C14H19NO苯基乙氨基2-酮6740-82-5
2-Keto-PCPrC15H21NO苯基正丙氨基2-酮
4-Methyl-PCPC18H27N苯基哌啶基4-甲基19420-52-1
4-Keto-PCP[9]C17H23NO苯基哌啶基4-酮65620-13-5
2'-Cl-PCPC17H24ClN邻氯苯基哌啶基-2201-31-2
3'-Cl-PCPC17H24ClN间氯苯基哌啶基-2201-32-3
2'-MeO-PCPC18H27NO邻甲氧基苯基哌啶基-2201-34-5
3'-F-PCP[10]C17H24FN间氟苯基哌啶基-89156-99-0
3'-Me-PCP[11]C18H27N间甲苯基哌啶基-2201-30-1
3'-Me-PCPyC17H25N间甲苯基吡咯基-1622348-63-3
3'-NH2-PCPC17H26N2间氨基苯基哌啶基-72242-00-3
3-羥基苯環己哌啶（3'-HO-PCP）C17H25NO间羟基苯基哌啶基-79787-43-2
3-甲氧基苯環己哌啶（3'-MeO-PCP）C18H27NO间甲氧基苯基哌啶基-72242-03-6
3',4'-MD-PCP3,4-亚甲二氧基苯基哌啶基-
3'-MeO-PCE间甲氧基苯基乙氨基-1364933-80-1
3'-HO-PCE间羟基苯基乙氨基-
3'-MeO-PCPr间甲氧基苯基正丙氨基-1364933-81-2
3'-HO-PCPr间羟基苯基正丙氨基-
3',4'-MD-PCPr3,4-亚甲二氧基苯基正丙氨基-
3'-MeO-PCPy[11]间甲氧基苯基吡咯基-1364933-79-8
4-羥基苯環己哌啶（4'-HO-PCP）C17H25NO对羟基苯基哌啶基-66568-88-5
4-甲氧基苯環己哌啶（4'-MeO-PCP）C18H27NO对甲氧基苯基哌啶基-2201-35-6
4'-MeO-PCE对甲氧基苯基乙氨基-
4'-F-PCP[10]p-Fluorophenyl哌啶基-22904-99-0
4'-F-PCPyp-Fluorophenyl吡咯基-
ArketamineC13H16ClNO邻氯苯基甲氨基2-酮33643-49-1
DeschloroketamineC13H17NO苯基甲氨基2-酮7063-30-1
EsketamineC13H16ClNO邻氯苯基甲氨基2-酮33643-46-8
氯胺酮C13H16ClNO邻氯苯基甲氨基2-酮6740-88-1
HydroxynorketamineC12H14ClNO2邻氯苯基NH22-酮,6-羟基81395-70-2
EthketamineC14H18ClNO邻氯苯基乙氨基2-酮1354634-10-8
NPNKC15H20ClNO邻氯苯基正丙氨基2-酮2749326-65-4
MethoxyketamineC14H19NO2邻甲氧基苯基甲氨基2-酮7063-51-6
2-MeO-NEK[12]C15H21NO2邻甲氧基苯基乙氨基2-酮
oMDCK[13]C14H19NO邻甲苯基甲氨基2-酮7063-37-8
mMDCKC14H19NO间甲苯基甲氨基2-酮
meta-KetamineC13H16ClNO间氯苯基甲氨基2-酮7063-53-8
iso-KetamineC13H16ClNO邻氯苯基甲氨基4-酮
氟胺酮C13H16FNO邻氟苯基甲氨基2-酮111982-50-4
3-氟脱氯氯胺酮C13H16FNO间氟苯基甲氨基2-酮2657761-23-2
Bromoketamine邻溴苯基甲氨基2-酮120807-70-7
TFMDCKo-Trifluoromethylphenyl甲氨基2-酮1782149-73-8
SN 35210[14]邻氯苯基Carbomethoxybutylamino2-酮1450615-41-4
MethoxetamineC15H21NO2间甲氧基苯基乙氨基2-酮1239943-76-0
MethoxmetamineC14H19NO2间甲氧基苯基甲氨基2-酮1781829-56-8
MethoxpropamineC16H23NO2间甲氧基苯基正丙氨基2-酮2504100-71-2
MXiPrC16H23NO2间甲氧基苯基异丙氨基2-酮
EthoxetamineC16H23NO2间乙氧基苯基乙氨基2-酮
Deoxymethoxetamine (3-Me-2'-Oxo-PCE)间甲苯基乙氨基2-酮2666932-45-0
Br-MXE2-溴-5-甲氧基苯基乙氨基2-酮
Hydroxetamine (HXE)间羟基苯基乙氨基2-酮1620054-73-0
HXM间羟基苯基甲氨基2-酮
2F-NENDCKC14H18FNO邻氟苯基乙氨基2-酮
Fluorexetamine (FXE)C14H18FNO间氟苯基乙氨基2-酮
苯环己哌啶（PCP）C17H25N苯基哌啶基-77-10-1
PC3MPC18H27N苯基3-甲基哌啶基-2201-41-4
PC4MPC18H27N苯基4-甲基哌啶基-2201-42-5
咯环利定（PCPy）C16H23N苯基吡咯基-2201-39-0
PCDMPyC18H27N苯基3,3-二甲基吡咯基-
PCMoC16H23NO苯基吗啉基-2201-40-3
Methoxy-PCM[15] (2'-MeO-PCMo)邻甲氧基苯基Morpholine-1314323-88-0
3'-MeO-PCMo间甲氧基苯基Morpholine-138873-80-0
4'-MeO-PCMo对间甲氧基苯基Morpholine-
Methyl-PCM[16] (4'-Me-PCMo)对甲苯基Morpholine-120803-52-3
Hydroxy-methyl-PCM2-Methyl-4-hydroxyphenylMorpholine-1314323-89-1
PYCP [17]2-Pyridinyl哌啶基-
TCM2-噻吩基甲氨基-139401-07-3
TCE2-噻吩基乙氨基-101589-62-2
TCPr [18]2-噻吩基正丙氨基-
Tenocyclidine (TCP)2-噻吩基哌啶基-21500-98-1
T3CP3-噻吩基哌啶基-19420-50-9
TCPy2-噻吩基吡咯基-22912-13-6
Tiletamine2-噻吩基乙氨基2-酮14176-49-9
MXTE4-Methoxy-2-thienyl乙氨基2-酮
Gacyclidine2-噻吩基哌啶基2-Methyl68134-81-6
BDPCp-BromophenylDimethylamino4-Phenethyl-4-hydroxy77239-98-6
C-8813p-BromophenylDimethylamino4-(thiophen-2-yl)ethyl-4-hydroxy616898-54-5
Dimetamine[19]对甲苯基Dimethylamino4-酮65619-06-9
3''-OH-2'-Me-PCP [20]C18H27NO邻甲苯基3-Hydroxypiperidine-
4''-Ph-4''-OH-PCP [21]苯基4-Phenyl-4-hydroxypiperidine-77179-39-6
BTCP[22]Benzothiophen-2-yl哌啶基-112726-66-6
BTCPy[23]Benzothiophen-2-yl吡咯基-
GK-189[24]Naphthalen-2-yl哌啶基-81490-58-6

参考文献
  1. . CAS Number Search - chemsrc.com. chemsrc. [15 March 2021].
  2. Thurkauf A, de Costa B, Yamaguchi S, Mattson MV, Jacobson AE, Rice KC, Rogawski MA. . Journal of Medicinal Chemistry. May 1990, 33 (5): 1452–8. PMID 2329567. doi:10.1021/jm00167a027.
  3. Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH. . Journal of Chromatography A. April 2008, 1186 (1–2): 380–90. PMID 18035363. doi:10.1016/j.chroma.2007.11.002.
  4. Kalir A, Teomy S, Amir A, Fuchs P, Lee SA, Holsztynska EJ, et al. . Journal of Medicinal Chemistry. October 1984, 27 (10): 1267–71. PMID 6481761. doi:10.1021/jm00376a006.
  5. Sauer C, Peters FT, Schwaninger AE, Meyer MR, Maurer HH. . Biochemical Pharmacology. February 2009, 77 (3): 444–50. PMID 19022226. doi:10.1016/j.bcp.2008.10.024.
  7. Iorio MA, Tomassini L, Mattson MV, George C, Jacobson AE. . Journal of Medicinal Chemistry. August 1991, 34 (8): 2615–23. PMID 1875352. doi:10.1021/jm00112a041.
  8. Ahmadi A, Mahmoudi A. . Arzneimittel-Forschung. 2006, 56 (5): 346–50. PMID 16821645. S2CID 10370245. doi:10.1055/s-0031-1296732.
  9. Ortiz DM, Custodio RJ, Abiero A, Botanas CJ, Sayson LV, Kim M, et al. . Addiction Biology. July 2021, 26 (4): e12981. PMID 33135332. S2CID 226234538. doi:10.1111/adb.12981.
  10. Ogunbadeniyi AM, Adejare A. . Journal of Fluorine Chemistry. 2002, 114: 39–42. doi:10.1016/S0022-1139(01)00565-6.
  11. Wallach J, De Paoli G, Adejare A, Brandt SD. . Drug Testing and Analysis. 2013, 6 (7–8): 633–50. PMID 23554350. doi:10.1002/dta.1468.
  12. Sayson LV, Botanas CJ, Custodio RJ, Abiero A, Kim M, Lee HJ, et al. . Psychopharmacology. July 2019, 236 (7): 2201–2210. PMID 30891619. S2CID 83463722. doi:10.1007/s00213-019-05219-x.
  13. WO 2021134086,Kruegel AC, Sames D, Hashimoto K,「Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders」,发表于1 July 2021,指定于Gilgamesh Pharmaceuticals, Inc.和The Trustees Of Columbia University In The City Of New York. （页面存档备份，存于）
  14. Harvey M, Sleigh J, Voss L, Pruijn F, Jose J, Gamage S, Denny W. . Pharmacology. 2015, 96 (5–6): 226–32. PMID 26352278. S2CID 36017002. doi:10.1159/000439598.
  16. Ahmadi A, Khalili M, Hajikhani R, Naserbakht M. . Arzneimittel-Forschung. 2011, 61 (2): 92–7. PMID 21428243. S2CID 8094521. doi:10.1055/s-0031-1296173.
  17. Zarantonello P, Bettini E, Paio A, Simoncelli C, Terreni S, Cardullo F. . Bioorganic & Medicinal Chemistry Letters. April 2011, 21 (7): 2059–63. PMID 21334205. doi:10.1016/j.bmcl.2011.02.009.
  18. Wallach J, Colestock T, Cicali B, Elliott SP, Kavanagh PV, Adejare A, et al. (PDF). Drug Testing and Analysis. August 2016, 8 (8): 801–15 [2024-02-23]. PMID 26360516. S2CID 1599386. doi:10.1002/dta.1861. （原始内容存档 (PDF)于2023-08-10）.
  19. Lednicer D, VonVoigtlander PF, Emmert DE. . Journal of Medicinal Chemistry. April 1980, 23 (4): 424–30. PMID 7381841. doi:10.1021/jm00178a014.
  20. Ahmadi A, Solati J, Hajikhani R, Onagh M, Javadi M. . Arzneimittel-Forschung. 2010, 60 (8): 492–6. PMID 20863005. S2CID 24803623. doi:10.1055/s-0031-1296317.
  21. Itzhak Y, Kalir A, Weissman BA, Cohen S. . Journal of Medicinal Chemistry. May 1981, 24 (5): 496–9. PMID 7241506. doi:10.1021/jm00137a004.
  22. Vignon J, Pinet V, Cerruti C, Kamenka JM, Chicheportiche R. . European Journal of Pharmacology. April 1988, 148 (3): 427–36. PMID 3384005. doi:10.1016/0014-2999(88)90122-7.
  24. . [2024-02-23]. （原始内容存档于2023-10-14）.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.